Journal of Bone Metabolism · 2012 · 16 citations · 13 references
MedicineOrthopaedic SurgeryOrthopedic SurgeryBone MetabolismCalcium HomeostasisMineral MetabolismBone Metabolism DisordersCalcium DisordersCalcium Gluconate TherapyCalcium MetabolismDisorders Of Calcium MetabolismVitamin D DeficiencyBisphosphonate Therapy ManagementCalcitriol TherapyFemur FracturesHypocalcemia TreatmentIntravenous Calcium AdministrationParathyroid DysfunctionParathyroid Gland FunctionTreatment With Bisphosphonates
Bisphosphonate generally seems to be safe, but hypocalcemia may occasionally develop in the course of bisphosphonate treatment. Hypocalcemia induced by bisphosphonate is usually mild and asymptomatic, but unrecognized or poorly treated hypocalcemia can lead to life-threatening state. A 78-year-old woman who had a history of hip arthroplasty and intravenous zoledronate treatment for femur neck fracture was presented to emergency department with altered mental status. It turned out that her symptom was due to severe hypocalcemia which was caused by intravenous zoledronate treatment. She also had renal dysfunction. She was treated by intravenous calcium gluconate and calcitriol administration. This case supports the need for evaluation of renal dysfunction, vitamin D deficiency and parathyroid gland dysfunction before bisphosphonate treatment and accurate monitoring of plasma calcium and creatinine levels. In addition, vitamin D and calcium supply during treatment with bisphosphonate is mandatory.
13
Lee S. Rosen, David Gordon, Simon Tchekmedyian et al. · Journal of Clinical Oncology · 2003 · 727 citations
Medicine, Oncology, Pharmacotherapy +17
Norio Kohno, Kenjiro Aogi, Hironobu Minami et al. · Journal of Clinical Oncology · 2005 · 545 citations
Medicine, Oncology, Pharmacotherapy +17